Monthly Archives: March 2010
Taking Medicine Up Close and Personal
How will ‘personalised medicine’ change pharmaceutical marketing? Continue reading
The Rudd Reforms: Outcome or Activity?
Sweeping heath system reforms were proposed in March. We look at the potential impact on the pharma and device sectors. Continue reading
Business Process Reform at the TGA
The TGA are proposing the most significant changes to the evaluation process for prescription medicines in nearly 20 years. In this article, the proposed changes are summarised and the potential effects for industry are discussed. Continue reading
The Top 5: APP Highlights
APP 2010 was held at the Gold Coast, March 11-13. Many remarked that the extremely well attended conference was the best ever, with topical speakers and a significantly increased exhibition space. If you couldn’t make it, our Top Five gives you a taste of the action. Continue reading
